St. Johns Investment Management Company LLC Has $919,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

St. Johns Investment Management Company LLC decreased its position in CVS Health Co. (NYSE:CVS) by 12.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 15,556 shares of the pharmacy operator’s stock after selling 2,243 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in CVS Health were worth $919,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Norges Bank bought a new position in shares of CVS Health in the 4th quarter valued at about $1,092,040,000. Capital International Investors boosted its stake in shares of CVS Health by 47.4% in the 4th quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator’s stock valued at $2,660,298,000 after purchasing an additional 10,837,801 shares during the last quarter. Pzena Investment Management LLC boosted its stake in shares of CVS Health by 573.8% in the 1st quarter. Pzena Investment Management LLC now owns 5,553,457 shares of the pharmacy operator’s stock valued at $442,944,000 after purchasing an additional 4,729,207 shares during the last quarter. Capital World Investors raised its position in shares of CVS Health by 8.0% in the 1st quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after acquiring an additional 3,232,172 shares during the period. Finally, Clearbridge Investments LLC raised its position in shares of CVS Health by 306.6% in the 4th quarter. Clearbridge Investments LLC now owns 3,046,216 shares of the pharmacy operator’s stock valued at $240,529,000 after acquiring an additional 2,297,100 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS traded down $0.05 during midday trading on Monday, reaching $58.70. 6,892,255 shares of the stock were exchanged, compared to its average volume of 11,262,376. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. The company has a market cap of $73.69 billion, a P/E ratio of 10.32, a PEG ratio of 0.57 and a beta of 0.52. The stock’s 50 day simple moving average is $58.81 and its 200 day simple moving average is $64.89.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.21 earnings per share. On average, sell-side analysts expect that CVS Health Co. will post 7 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.53%. The ex-dividend date was Monday, July 22nd. CVS Health’s payout ratio is 46.75%.

Wall Street Analyst Weigh In

CVS has been the topic of a number of analyst reports. Barclays cut their price target on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. Evercore ISI cut their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Leerink Partnrs downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Baird R W upgraded shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. Finally, Argus dropped their target price on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, May 8th. Eleven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $73.24.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.